Serum ferritin as a component of the insulin resistance syndrome

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 62-68

  Fernández Real, José Manuel ^a   Ricart Engel, Wifredo ^a   Arroyo, Enric ^d   Balançá, Rafael ^a   Casamitjana Abella, Roser ^b   Cabrero, Dolores ^a   Fernández Castañer, Miquel ^c   Soler, Joan ^c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST;

EID: 2642608680     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.62     Document Type: Article

References (48)

1. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86:803-811, 1992
2. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
3. Tuomainen T-P, Nyysönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT: Body iron stores are associated with serum insulin and blood glucose concentrations. Diabetes Care 20:426-428, 1997
4. Ascherio A, Willet WC, Rimm EB, Giovanucci EL, Stampfer MJ: Dietary iron intake and risk of coronary heart disease among men. Circulation 89:969-974, 1994
5. Sullivan JL: Stored iron and ischemic heart disease: empirical support for a new paradigm. Circulation 86:1036-1037, 1992
6. Lyons TJ: Oxidized low-density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes. Diabet Med 8:411-419, 1991
7. Hunt JV, Smith CC, Wolff SP: Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424, 1990
8. Wolff SP, Dean RT: Glucose autooxidation and protein oxidation: the role of autoxidative glycosylation in diabetes mellitus and ageing. Biochem J 245:243-250, 1987
9. Reif DW: Ferritin as a source of iron for oxidative damage. Free Rad Biol Med 12:417-427, 1992
10. Fujimoto S, Kawakami N, Ohara A: Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production. Biol Pharm Bull 6:396-400, 1995
11. Cook JD, Finch CA, Smith NJ: Evaluation of the iron stores of a population. Blood 3:449-455, 1976
12. Fernández-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernández-Castañer M, Vendrell J, Richart C, Soler J: The TNF-α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468-1472, 1997
13. Jeliffe DB: The Assessment of Nutritional Status of the Community. Geneva, World Health Org., 1966 (WHO Monographs Ser., no. 53)
14. Ricart W, Gonzalez-Huix F, Conde V, Grup per l'Evaluació de la Composició Corporal de la Població de Catalunya: The evaluation of the state of nutrition through the determination of anthropometric parameters: new tables in the working population in Catalonia (Spain). Med Clin (Barc) 100:681-691, 1993
15. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
16. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29: 1075-1080, 1983
17. Kostner GM, Molinari E, Pichler P: Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol. Clin Chim Acta 148:139-147, 1985
18. Wahlefeld AW. In Methoden der Enzymatischen Analyse. 3rd ed. Vol II. Bergmeyer HU, Ed. Weinheim, Germany, Verlag Chemie: 187-188, 1974
19. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 79:790-800, 1987
20. Saad MF, Steil GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R, Jinagouda SD, Bergman RN: Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46:1167-1171, 1997
21. Cederholm J, Wibell L: Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167-175, 1990
22. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
23. Oshaug A, Bugge KH, Bjønnes CH, Borch-Iohnsen B, Neslein I-L: Associations between serum ferritin and cardiovascular risk factors in healthy young men: a cross sectional study. Eur J Clin Nutr 49:430-438, 1995
24. Zidek W, Tenschert W, Karoff CH, Vetter H: Treatment of resistant hypertension by phlebotomy. Klin Wochenschr 63:762-764, 1985
25. Barenbrock M, Spieker C, Rahn KH, Zidek W: Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis. Clin Nephrol 40:241-243, 1993
26. Dávalos A, Fernández-Real JM, Ricart W, Soler S, Molins A, Planas E, Genís D: Iron related damage in acute ischemic stroke. Stroke 25:1543-1546, 1994
27. Fernández-Real JM: Iron as a cardiovascular risk factor: its interaction with classical risk factors. Med Clin (Barc) 105:617-619, 1995
28. Vuorinen-Markkola H, Yki-Jarvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29, 1994
29. Moirand R, Mortaji AM, Loréal O, Paillard F, Brissot P, Deugnier Y: A new syndrome of liver iron overload with normal transferrin saturation. Lancet 349:95-97, 1997
30. Milman N: Serum ferritin in Danes: studies of iron status from infancy to old. Int J Hematol 63:103-135, 1996
31. Bulaj ZB, Griffen LM, Jorde LB, Edwards CQ, Kushner JP: Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-1805, 1996
32. Sullivan JL: Iron versus cholesterol: perspectives on the iron and heart disease debate. J Clin Epidemiol 49:1345-1352, 1997
33. Felber J-P, Ferrannini E, Golay A, Meyer A, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350, 1987
34. DeFronzo RA: The triumvirate: β-cell, muscle, liver. Diabetes 37:667-687, 1988
35. Dandona P, Hussain MAM, Varghese Z, Politis D, Flynn DM, Hoffbrand AV: Insulin resistance and iron overload. Ann Clin Biochem 20:77-79, 1983
36. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegel E, Creutzfeldt W: Hyperinsulinemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 26:441-444, 1984
37. Shafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS, Bunn HF: Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 304:319-324, 1981
38. Katz LD, Glickman MG, Rapoport S, Ferrannini E, DeFronzo RA: Splanchnic and peripheral glucose disposal of oral glucose in man. Diabetes 32:675-679, 1983
39. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV: Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 318:809-814, 1988
40. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B: Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab 77:478-483, 1993
41. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, Piga A, Pagano G: Insulin resistance and hyperinsulinemia in homozygous β-thalassemia. Metabolism 44:281-286, 1995
42. Wannamethee SG, Perry IJ, Shaper AG: Hematocrit and risk of NIDDM. Diabetes 45:576-579, 1996
43. Catalano C, Muscelli E, Quiñones A, Baldi S, Ciociaro D, Seghieri G, Ferrannini E: Reciprocal association between insulin sensitivity and the hematocrit in man (Abstract). Diabetes 45 (Suppl. 2):323A, 1996
44. Wilson PW, McGee DL, Kannel WB: Obesity, very low density lipoproteins and glucose intolerance over fourteen years: the Framingham Study. Am J Epidemiol 114:697-704, 1981
45. Medalie JH, Papier CM, Goldbourt U, Herman JB: Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 135:811-817, 1975
46. Kaye TB, Guay AT, Simonson DC: Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabet Complications 7:246-249, 1993
47. Gallou G, Guilhem I, Poirier J-Y, Ruelland A, Legras B, Cloarec L: Increased serum ferritin in insulin-dependent diabetes mellitus: relation to glycemic control. Clin Chem 40:947-948, 1994
48. Mauricio D, Pérez A, Riera A, Arroyo JA, de Leiva A, Gimferrer E: Serum parameters of iron metabolism in type I (insulin dependent) diabetes mellitus. Diabetes Nutr Metab 8:315-316, 1993